FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 1 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $279 | -27.7% | 710 | -11.7% | 0.00% | – |
| Q4 2022 | $386 | -61.4% | 804 | -2.3% | 0.00% | – |
| Q3 2022 | $1,000 | -98.7% | 823 | -97.0% | 0.00% | – |
| Q2 2022 | $78,000 | -39.5% | 27,605 | +7.1% | 0.00% | – |
| Q1 2022 | $129,000 | -52.7% | 25,773 | -6.0% | 0.00% | – |
| Q4 2021 | $273,000 | +11.9% | 27,411 | +45.9% | 0.00% | – |
| Q3 2021 | $244,000 | +1120.0% | 18,789 | +1212.1% | 0.00% | – |
| Q2 2021 | $20,000 | – | 1,432 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|